hrcak mascot   Srce   HID

Pregledni rad

APPLICATION OF OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA/ANGIOEDEMA: RECOMMENDATIONS, EXPERIENCE AND PERCEPTIONS

LIBORIJA LUGOVIĆ-MIHIĆ   ORCID icon orcid.org/0000-0001-7494-5742 ; Sestre milosrdnice University Hospital Centre, Department of Dermatovenereology, Zagreb, and University of Zagreb, School of Dental Medicine, Zagreb, Croatia
IVA FERČEK ; Sestre milosrdnice University Hospital Centre, Department of Dermatovenereology, Zagreb, Croatia
IVA BUKVIĆ ; Sestre milosrdnice University Hospital Centre, Department of Dermatovenereology, Zagreb, and University of Zagreb, School of Dental Medicine, Zagreb, Croatia
TOMISLAV DUVANČIĆ   ORCID icon orcid.org/0000-0002-6121-3232 ; Sestre milosrdnice University Hospital Centre, Department of Dermatovenereology, Zagreb, and University of Zagreb, School of Dental Medicine, Zagreb, Croatia

Puni tekst: hrvatski, pdf (127 KB) str. 495-501 preuzimanja: 218* citiraj
APA 6th Edition
LUGOVIĆ-MIHIĆ, L., FERČEK, I., BUKVIĆ, I. i DUVANČIĆ, T. (2018). PRIMJENA OMALIZUMABA KOD KRONIČNE SPONTANE URTIKARIJE/ANGIOEDEMA: PREPORUKE, ISKUSTVA I SPOZNAJE. Acta medica Croatica, 72 (4), 495-501. Preuzeto s https://hrcak.srce.hr/216547
MLA 8th Edition
LUGOVIĆ-MIHIĆ, LIBORIJA, et al. "PRIMJENA OMALIZUMABA KOD KRONIČNE SPONTANE URTIKARIJE/ANGIOEDEMA: PREPORUKE, ISKUSTVA I SPOZNAJE." Acta medica Croatica, vol. 72, br. 4, 2018, str. 495-501. https://hrcak.srce.hr/216547. Citirano 20.10.2019.
Chicago 17th Edition
LUGOVIĆ-MIHIĆ, LIBORIJA, IVA FERČEK, IVA BUKVIĆ i TOMISLAV DUVANČIĆ. "PRIMJENA OMALIZUMABA KOD KRONIČNE SPONTANE URTIKARIJE/ANGIOEDEMA: PREPORUKE, ISKUSTVA I SPOZNAJE." Acta medica Croatica 72, br. 4 (2018): 495-501. https://hrcak.srce.hr/216547
Harvard
LUGOVIĆ-MIHIĆ, L., et al. (2018). 'PRIMJENA OMALIZUMABA KOD KRONIČNE SPONTANE URTIKARIJE/ANGIOEDEMA: PREPORUKE, ISKUSTVA I SPOZNAJE', Acta medica Croatica, 72(4), str. 495-501. Preuzeto s: https://hrcak.srce.hr/216547 (Datum pristupa: 20.10.2019.)
Vancouver
LUGOVIĆ-MIHIĆ L, FERČEK I, BUKVIĆ I, DUVANČIĆ T. PRIMJENA OMALIZUMABA KOD KRONIČNE SPONTANE URTIKARIJE/ANGIOEDEMA: PREPORUKE, ISKUSTVA I SPOZNAJE. Acta medica Croatica [Internet]. 2018 [pristupljeno 20.10.2019.];72(4):495-501. Dostupno na: https://hrcak.srce.hr/216547
IEEE
L. LUGOVIĆ-MIHIĆ, I. FERČEK, I. BUKVIĆ i T. DUVANČIĆ, "PRIMJENA OMALIZUMABA KOD KRONIČNE SPONTANE URTIKARIJE/ANGIOEDEMA: PREPORUKE, ISKUSTVA I SPOZNAJE", Acta medica Croatica, vol.72, br. 4, str. 495-501, 2018. [Online]. Dostupno na: https://hrcak.srce.hr/216547. [Citirano: 20.10.2019.]

Sažetak
Patients with chronic urticaria (CU), with hives for more than 6 weeks, often experience problems with the unpredictability of hives, social isolation, decreased sleep quality due to associated itchiness and fatigue. In almost half of patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) the cause of the condition was undetermined but 30%-50% of patients were found to produce IgG autoantibodies directed against IgE or its high affinity receptors (Fc

Ključne riječi
chronic urticaria; therapy; omalizumab; chronic idiopathic/spontaneous urticaria

Hrčak ID: 216547

URI
https://hrcak.srce.hr/216547

[hrvatski]

Posjeta: 316 *